PD1 Antibody
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC (NCT06896422) | The First Affiliated Hospital of Zhengzhou University | 2025-06-01 |
| Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT04669496) | Shanghai Zhongshan Hospital | 2021-01-20 |
| Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging (NCT07581769) | First Affiliated Hospital, Sun Yat-Sen University | 2018-01-01 |
Track PD1 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.